F.D.A. Names Agency Veteran to Run Drug Divisionnews2025-11-12T03:18:48+00:00November 12th, 2025|The New York Times|
What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
The Workers Left Out of Trump’s Drug-Manufacturing Renaissancenews2025-11-04T10:00:29+00:00November 4th, 2025|The New York Times|
F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Companynews2025-11-03T03:40:45+00:00November 3rd, 2025|The New York Times|
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugsnews2025-10-29T20:07:07+00:00October 29th, 2025|The New York Times|
Texas demanda a los fabricantes de Tylenol por supuesto encubrimiento de riesgos de autismonews2025-10-28T16:54:47+00:00October 28th, 2025|The New York Times|
Texas Sues Tylenol Makers, Claiming They Hid Autism Risksnews2025-10-28T12:24:44+00:00October 28th, 2025|The New York Times|
La testosterona devuelve a las mujeres su deseo sexual, pero hay algo másnews2025-10-25T09:01:44+00:00October 25th, 2025|The New York Times|
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Pricesnews2025-10-23T09:00:45+00:00October 23rd, 2025|The New York Times|
How Testosterone Is Giving Middle-Aged Women the Best Sex of Their Livesnews2025-10-22T09:00:59+00:00October 22nd, 2025|The New York Times|